No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission-Reference-Cited by-同舟云学术

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

Published:2000-08 Issue:2 Volume:110 Page:308-314
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Cahn Jean-Yves,Labopin Myriam,Sierra Jorge,Blaise Didier,Reiffers Josy,Ferrant Augustin,Bergmann Lothar,Visani Giuseppe,Cornelissen Jan,De Witte Theo,Bosi Alberto,Frassoni Francesco,Gorin Norbert-Claude,

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.02178.x/fullpdf

Reference18 articles.

1. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia;Bishop;Blood,1996

2. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype;Bloomfield;Cancer Research,1998

3. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial;Burnett;Lancet,1998

4. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission;Cassileth;New England Journal of Medicine,1998

5. High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia;Cole;Blood Reviews,1997

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mythological chimera and new era of relapse prediction post-transplant;Blood Reviews;2023-01

2. More than two courses of pre-transplant consolidation therapy benefits patients with acute myeloid leukemia in the first complete remission who underwent human leukocyte antigen-matched sibling allografts: a multicenter study;Chinese Medical Journal;2022-11-08

3. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients;Leukemia;2022-10-30

4. Consolidation in AML: Abundant opinion and much unknown;Blood Reviews;2022-01

5. Eradication of Measurable Residual Disease in AML: A Challenging Clinical Goal;Cancers;2021-06-25